MENU
ATYR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

aTyr Pharma (ATYR) Ownership - Who owns aTyr Pharma?

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
46.1M
P/E Ratio
N/A
Total Cash
66.51M
Projected Growth
N/A
Total Debt
11.7M
Revenue
190K
Risk (Beta)
0.75
Dividend Yield
N/A
Total Cash/Share
0.68
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
View a ticker or compare two or three
ATYR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details